Edgewise Therapeutics's total assets for Q3 2024 were $511.28M, a decrease of -3.83% from the previous quarter. EWTX total liabilities were $22.41M for the fiscal quarter, a 5.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.